Editorial & Opinion
An Integrative Genomic Strategy Identifies Soluble Receptor for Advanced Glycation End-Products as a Causal and Protective Biomarker of Lung Function.
| العنوان: | An Integrative Genomic Strategy Identifies Soluble Receptor for Advanced Glycation End-Products as a Causal and Protective Biomarker of Lung Function. |
|---|---|
| المؤلفون: | Wiersma VR; Department of Hematology, Cancer Research Center Groningen, Groningen, The Netherlands., Pouwels SD; Departments of Pathology and Medical Biology and Pulmonary Diseases, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: s.d.pouwels@umcg.nl. |
| المصدر: | Chest [Chest] 2022 Jan; Vol. 161 (1), pp. 3-5. |
| نوع المنشور: | Editorial; Comment |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Internet ISSN: 1931-3543 (Electronic) Linking ISSN: 00123692 NLM ISO Abbreviation: Chest Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2016- : New York : Elsevier Original Publication: Chicago : American College of Chest Physicians |
| مواضيع طبية MeSH: | Genomics* , Glycation End Products, Advanced*, Biomarkers ; Humans ; Lung ; Receptor for Advanced Glycation End Products/genetics |
| التعليقات: | Comment on: Chest. 2022 Jan;161(1):76-84. (PMID: 34237330) |
| المشرفين على المادة: | 0 (Biomarkers) 0 (Glycation End Products, Advanced) 0 (Receptor for Advanced Glycation End Products) |
| تواريخ الأحداث: | Date Created: 20220110 Date Completed: 20220214 Latest Revision: 20220214 |
| رمز التحديث: | 20240628 |
| DOI: | 10.1016/j.chest.2021.08.005 |
| PMID: | 35000706 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1931-3543 |
|---|---|
| DOI: | 10.1016/j.chest.2021.08.005 |